HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Lip Cancer

Lip Cancer

Lip cancer, a subtype of oral cancer, poses a significant health concern globally. Research in this field delves into various aspects, including risk factors, early detection methods, and treatment modalities. Studies highlight the role of tobacco and alcohol consumption as primary risk factors, emphasizing the importance of lifestyle modifications for prevention. Furthermore, advancements in molecular biology have led to the identification of genetic markers associated with lip cancer, aiding in personalized treatment approaches. Early detection techniques such as screening programs and innovative imaging technologies offer promising avenues for timely intervention. Additionally, ongoing research explores novel therapeutic strategies, including targeted drug therapies and immunotherapies, to improve patient outcomes. Collaborative efforts among researchers, healthcare professionals, and policymakers are crucial in advancing lip cancer research and addressing the growing burden of this disease.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp